We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lab-on-a-Chip Promises Biochemical Diagnostics

By LabMedica International staff writers
Posted on 06 Mar 2013
Lab-on-a-chip technologies are attractive as they require fewer reagents, have lower detection limits, allow for parallel analyses, and can have a smaller footprint.

Miniaturized laboratory-on-chip systems promise rapid, sensitive, and multiplexed detection of biological samples for medical diagnostics, and high-throughput screening.

Scientists at the University of Illinois (Urbana, IL USA) used microfabrication techniques and incorporated a unique design of transistor-based heating, for further advancing the use of silicon transistor and electronics into chemistry and biology for point-of-care diagnostics.

The approach performs localized heating of individual subnanoliter droplets that can allow for new applications that require parallel, time-and space-multiplex reactions on a single integrated circuit. Within miniaturized laboratory-on-chips, static and dynamic droplets of fluids in different immiscible media have been used as individual vessels to perform biochemical reactions and confine the products.

By using microfabrication techniques and incorporating the unique design of transistor-based heating with individual reaction volumes, “laboratory-on-a-chip” technologies can be scaled down to “laboratory-on-a-transistor” technologies as sensor/heater hybrids that could be used for point-of-care diagnostics.

Rashid Bashir, PhD, a professor at the University of Illinois said, “We have demonstrated that single stranded DNA (ssDNA) probe molecules can be placed on heaters in solution, dried, and then rehydrated by ssDNA target molecules in droplets for hybridization and detection. This platform enables many applications in droplets including hybridization of low copy number DNA molecules, lysing of single cells, interrogation of ligand-receptor interactions, and rapid temperature cycling for amplification of DNA molecules. Notably, our miniaturized heater could also function as dual heater/sensor elements, as these silicon-on-insulator nanowire or nanoribbon structures have been used to detect DNA, proteins, pH, and pyrophosphates.”

The authors concluded that the technique they described to heat subnanoliter droplets-in-air for visualization of DNA denaturation with resolution down to single base mismatches has application to current DNA microarray technologies. The study was published on February 11, 2013, in the journal Proceedings of the National Academy of Science of the United States of America (PNAS).

Related Links:

University of Illinois


Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Pipette Calibration System
Artel PCS®

Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
ADLM